Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Asthma

  Free Subscription


Articles published in Respir Res

Retrieve available abstracts of 55 articles:
HTML format



Single Articles


    November 2021
  1. SVERRILD A, Leadbetter J, Porsbjerg C
    The use of the mannitol test as an outcome measure in asthma intervention studies: a review and practical recommendations.
    Respir Res. 2021;22:287.
    PubMed     Abstract available


    October 2021
  2. HARDING JN, Gross M, Patel V, Potter S, et al
    Association between particulate matter containing EPFRs and neutrophilic asthma through AhR and Th17.
    Respir Res. 2021;22:275.
    PubMed     Abstract available


  3. TUPPER OD, Ulrik CS
    Long-term predictors of severe exacerbations and mortality in a cohort of well-characterised adults with asthma.
    Respir Res. 2021;22:269.
    PubMed     Abstract available


    September 2021
  4. RYBKA-FRACZEK A, Dabrowska M, Grabczak EM, Bialek-Gosk K, et al
    Does bronchial hyperresponsiveness predict a diagnosis of cough variant asthma in adults with chronic cough: a cohort study.
    Respir Res. 2021;22:252.
    PubMed     Abstract available


    July 2021
  5. WARREN KJ, Poole JA, Sweeter JM, DeVasure JM, et al
    Neutralization of IL-33 modifies the type 2 and type 3 inflammatory signature of viral induced asthma exacerbation.
    Respir Res. 2021;22:206.
    PubMed     Abstract available


  6. O'BEIRNE SL, Salit J, Kaner RJ, Crystal RG, et al
    Up-regulation of ACE2, the SARS-CoV-2 receptor, in asthmatics on maintenance inhaled corticosteroids.
    Respir Res. 2021;22:200.
    PubMed     Abstract available


    June 2021
  7. PAPAKONSTANTINOU E, Koletsa T, Zhou L, Fang L, et al
    Bronchial thermoplasty in asthma: an exploratory histopathological evaluation in distinct asthma endotypes/phenotypes.
    Respir Res. 2021;22:186.
    PubMed     Abstract available


  8. LEMIERE C, Taille C, Lee JK, Smith SG, et al
    Impact of baseline clinical asthma characteristics on the response to mepolizumab: a post hoc meta-analysis of two Phase III trials.
    Respir Res. 2021;22:184.
    PubMed     Abstract available


  9. MO Y, Ye L, Cai H, Zhu G, et al
    SERPINB10 contributes to asthma by inhibiting the apoptosis of allergenic Th2 cells.
    Respir Res. 2021;22:178.
    PubMed     Abstract available


  10. WARDZYNSKA A, Pawelczyk M, Rywaniak J, Makowska J, et al
    Circulating miRNA expression in asthmatics is age-related and associated with clinical asthma parameters, respiratory function and systemic inflammation.
    Respir Res. 2021;22:177.
    PubMed     Abstract available


  11. GIBSON PG, Prazma CM, Chupp GL, Bradford ES, et al
    Mepolizumab improves clinical outcomes in patients with severe asthma and comorbid conditions.
    Respir Res. 2021;22:171.
    PubMed     Abstract available


  12. ABDO M, Uddin M, Goldmann T, Marwitz S, et al
    Raised sputum extracellular DNA confers lung function impairment and poor symptom control in an exacerbation-susceptible phenotype of neutrophilic asthma.
    Respir Res. 2021;22:167.
    PubMed     Abstract available


  13. KUROKAWA A, Kondo M, Arimura K, Ashino S, et al
    Less airway inflammation and goblet cell metaplasia in an IL-33-induced asthma model of leptin-deficient obese mice.
    Respir Res. 2021;22:166.
    PubMed     Abstract available


    May 2021
  14. PADILLA-GALO A, Garcia-Ruiz AJ, Levy Abitbol RC, Olveira C, et al
    Real-life cost-effectiveness of benralizumab in patients with severe asthma.
    Respir Res. 2021;22:163.
    PubMed     Abstract available


  15. LAMB D, De Sousa D, Quast K, Fundel-Clemens K, et al
    RORgammat inhibitors block both IL-17 and IL-22 conferring a potential advantage over anti-IL-17 alone to treat severe asthma.
    Respir Res. 2021;22:158.
    PubMed     Abstract available


  16. PERTZOV B, Ronen M, Rosengarten D, Shitenberg D, et al
    Use of capnography for prediction of obstruction severity in non-intubated COPD and asthma patients.
    Respir Res. 2021;22:154.
    PubMed     Abstract available


  17. LIU MC, Chipps B, Munoz X, Devouassoux G, et al
    Benefit of switching to mepolizumab from omalizumab in severe eosinophilic asthma based on patient characteristics.
    Respir Res. 2021;22:144.
    PubMed     Abstract available


  18. WANG T, Zhou Y, Kong N, Zhang J, et al
    Weight gain from early to middle adulthood increases the risk of incident asthma later in life in the United States: a retrospective cohort study.
    Respir Res. 2021;22:139.
    PubMed     Abstract available


  19. RAHERISON-SEMJEN C, Parrat E, Nocent-Eijnani C, Mangiapan G, et al
    FASE-CPHG Study: identification of asthma phenotypes in the French Severe Asthma Study using cluster analysis.
    Respir Res. 2021;22:136.
    PubMed     Abstract available


    April 2021
  20. HEALY C, Munoz-Wolf N, Strydom J, Faherty L, et al
    Nutritional immunity: the impact of metals on lung immune cells and the airway microbiome during chronic respiratory disease.
    Respir Res. 2021;22:133.
    PubMed     Abstract available


  21. CHEN A, Diaz-Soto MP, Sanmamed MF, Adams T, et al
    Single-cell characterization of a model of poly I:C-stimulated peripheral blood mononuclear cells in severe asthma.
    Respir Res. 2021;22:122.
    PubMed     Abstract available


  22. WORTH H, Criee CP, Vogelmeier CF, Kardos P, et al
    Prevalence of overuse of short-acting beta-2 agonists (SABA) and associated factors among patients with asthma in Germany.
    Respir Res. 2021;22:108.
    PubMed     Abstract available


  23. SADATSAFAVI M, Khakban A, Tavakoli H, Ehteshami-Afshar S, et al
    Trends in oral corticosteroids use in severe asthma: a 14-year population-based study.
    Respir Res. 2021;22:103.
    PubMed     Abstract available


    March 2021
  24. SHAHANGIAN K, Ngan DA, Chen HHR, Oh Y, et al
    IL-4Ralpha blockade reduces influenza-associated morbidity in a murine model of allergic asthma.
    Respir Res. 2021;22:75.
    PubMed     Abstract available


    February 2021
  25. WU TD, Fawzy A, Kinney GL, Bon J, et al
    Metformin use and respiratory outcomes in asthma-COPD overlap.
    Respir Res. 2021;22:70.
    PubMed     Abstract available


  26. CALMES D, Huynen P, Paulus V, Henket M, et al
    Chronic infection with Chlamydia pneumoniae in asthma: a type-2 low infection related phenotype.
    Respir Res. 2021;22:72.
    PubMed     Abstract available


  27. LI LY, Yan TS, Yang J, Li YQ, et al
    Impulse oscillometry for detection of small airway dysfunction in subjects with chronic respiratory symptoms and preserved pulmonary function.
    Respir Res. 2021;22:68.
    PubMed     Abstract available


  28. BEKAERT S, Rocks N, Vanwinge C, Noel A, et al
    Asthma-related inflammation promotes lung metastasis of breast cancer cells through CCL11-CCR3 pathway.
    Respir Res. 2021;22:61.
    PubMed     Abstract available


  29. SAITO T, Ichikawa T, Numakura T, Yamada M, et al
    PGC-1alpha regulates airway epithelial barrier dysfunction induced by house dust mite.
    Respir Res. 2021;22:63.
    PubMed     Abstract available


  30. KERMANI NZ, Song WJ, Badi Y, Versi A, et al
    Correction to: Sputum ACE2, TMPRSS2 and FURIN gene expression in severe neutrophilic asthma.
    Respir Res. 2021;22:47.
    PubMed    


  31. VAN DEN BERG MPM, Nijboer-Brinksma S, Bos IST, van den Berge M, et al
    The novel TRPA1 antagonist BI01305834 inhibits ovalbumin-induced bronchoconstriction in guinea pigs.
    Respir Res. 2021;22:48.
    PubMed     Abstract available


  32. WANG Y, Liao K, Liu B, Niu C, et al
    GITRL on dendritic cells aggravates house dust mite-induced airway inflammation and airway hyperresponsiveness by modulating CD4(+) T cell differentiation.
    Respir Res. 2021;22:46.
    PubMed     Abstract available


  33. HU Y, Chen Y, Liu S, Jiang F, et al
    Breastfeeding duration modified the effects of neonatal and familial risk factors on childhood asthma and allergy: a population-based study.
    Respir Res. 2021;22:41.
    PubMed     Abstract available


  34. TAKEUCHI H, Hasan SMT, Zaman K, Takanashi S, et al
    Impact of Haemophilus influenzae type b combination vaccination on asthma symptoms and pneumonia in 5-year-old children in rural Bangladesh: a longitudinal study and comparison with a previous cross-sectional study.
    Respir Res. 2021;22:35.
    PubMed     Abstract available


    January 2021
  35. FENG Z, Wang J, Xie Y, Li J, et al
    Effects of exercise-based pulmonary rehabilitation on adults with asthma: a systematic review and meta-analysis.
    Respir Res. 2021;22:33.
    PubMed     Abstract available


  36. SCHLEICH F, Graff S, Guissard F, Henket M, et al
    Asthma in elderly is characterized by increased sputum neutrophils, lower airway caliber variability and air trapping.
    Respir Res. 2021;22:15.
    PubMed     Abstract available


  37. KERMANI NZ, Song WJ, Badi Y, Versi A, et al
    Sputum ACE2, TMPRSS2 and FURIN gene expression in severe neutrophilic asthma.
    Respir Res. 2021;22:10.
    PubMed     Abstract available


    November 2020
  38. ALNAJEM A, Redha A, Alroumi D, Alshammasi A, et al
    Use of electronic cigarettes and secondhand exposure to their aerosols are associated with asthma symptoms among adolescents: a cross-sectional study.
    Respir Res. 2020;21:300.
    PubMed     Abstract available


    October 2020
  39. SINGH D, Virchow JC, Canonica GW, Vele A, et al
    Determinants of response to inhaled extrafine triple therapy in asthma: analyses of TRIMARAN and TRIGGER.
    Respir Res. 2020;21:285.
    PubMed     Abstract available


  40. ABDO M, Watz H, Veith V, Kirsten AM, et al
    Small airway dysfunction as predictor and marker for clinical response to biological therapy in severe eosinophilic asthma: a longitudinal observational study.
    Respir Res. 2020;21:278.
    PubMed     Abstract available


  41. MENZIES-GOW A, Ponnarambil S, Downie J, Bowen K, et al
    DESTINATION: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the long-term safety and tolerability of tezepelumab in adults and adolescents with severe, uncontrolled asthma.
    Respir Res. 2020;21:279.
    PubMed     Abstract available


  42. GROTH EE, Weber M, Bahmer T, Pedersen F, et al
    Exploration of the sputum methylome and omics deconvolution by quadratic programming in molecular profiling of asthma and COPD: the road to sputum omics 2.0.
    Respir Res. 2020;21:274.
    PubMed     Abstract available


  43. MENZIES-GOW A, Wechsler ME, Brightling CE
    Unmet need in severe, uncontrolled asthma: can anti-TSLP therapy with tezepelumab provide a valuable new treatment option?
    Respir Res. 2020;21:268.
    PubMed     Abstract available


  44. MENZIES-GOW A, Colice G, Griffiths JM, Almqvist G, et al
    NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma.
    Respir Res. 2020;21:266.
    PubMed     Abstract available


  45. WECHSLER ME, Colice G, Griffiths JM, Almqvist G, et al
    SOURCE: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of tezepelumab in reducing oral corticosteroid use in adults with oral corticosteroid dependent asthma.
    Respir Res. 2020;21:264.
    PubMed     Abstract available


  46. EMSON C, Diver S, Chachi L, Megally A, et al
    CASCADE: a phase 2, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the effect of tezepelumab on airway inflammation in patients with uncontrolled asthma.
    Respir Res. 2020;21:265.
    PubMed     Abstract available


    September 2020
  47. MATUSIAK M, Schurch CM
    Expression of SARS-CoV-2 entry receptors in the respiratory tract of healthy individuals, smokers and asthmatics.
    Respir Res. 2020;21:252.
    PubMed     Abstract available


  48. MILLER D, Vaidya S, Jauernig J, Ethell B, et al
    Lung function, pharmacokinetics, and tolerability of inhaled indacaterol maleate and acetate in asthma patients.
    Respir Res. 2020;21:248.
    PubMed     Abstract available


    July 2020
  49. ABDULNASSER HARFOUSH S, Hannig M, Le DD, Heck S, et al
    High-dose intranasal application of titanium dioxide nanoparticles induces the systemic uptakes and allergic airway inflammation in asthmatic mice.
    Respir Res. 2020;21:168.
    PubMed     Abstract available


    May 2020
  50. XU W, Wang Y, Ma Y, Yang J, et al
    MiR-223 plays a protecting role in neutrophilic asthmatic mice through the inhibition of NLRP3 inflammasome.
    Respir Res. 2020;21:116.
    PubMed     Abstract available


    March 2020
  51. LANGTON D, Bennetts K, Noble P, Plummer V, et al
    Bronchial thermoplasty reduces airway resistance.
    Respir Res. 2020;21:76.
    PubMed     Abstract available


    February 2020
  52. GOORSENBERG AWM, d'Hooghe JNS, Slats AM, van den Aardweg JG, et al
    Resistance of the respiratory system measured with forced oscillation technique (FOT) correlates with bronchial thermoplasty response.
    Respir Res. 2020;21:52.
    PubMed     Abstract available


  53. XIE M, Liu X, Cao X, Guo M, et al
    Trends in prevalence and incidence of chronic respiratory diseases from 1990 to 2017.
    Respir Res. 2020;21:49.
    PubMed     Abstract available


    January 2020
  54. JIANG JX, Shen HJ, Guan Y, Jia YL, et al
    ZDHXB-101 (3',5-Diallyl-2, 4'-dihydroxy-[1,1'-biphen-yl]-3,5'-dicarbaldehyde) protects against airway remodeling and hyperresponsiveness via inhibiting both the activation of the mitogen-activated protein kinase and the signal transducer and activator
    Respir Res. 2020;21:22.
    PubMed     Abstract available


  55. WALSCHER J, Gross B, Morisset J, Johannson KA, et al
    Comorbidities and survival in patients with chronic hypersensitivity pneumonitis.
    Respir Res. 2020;21:12.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Asthma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: